Respiratory Devices And Equipment (Therapeutic) Market Definition And Segments

Respiratory devices and equipment (therapeutic) are used to treat patients with acute or chronic respiratory disorders such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, sleep disorders, etc. The main products of the respiratory devices and equipment (therapeutic) market are nebulizers, humidifiers, oxygen concentrators, positive airway pressure devices, ventilators, capnographs, and gas analyzers. A nebulizer is a small machine that turns liquid medicine into a mist, sits with the machine, and breathes in by a connected mouthpiece. The various technologies involved in the respiratory devices and equipment are HEPA filter, electrostatic filtration, microsphere separation, hollow fiber filtration, and others. The market covered in this report is segmented by end-users into home care settings and hospitals. The respiratory devices and equipment (therapeutic) market covered in this report is segmented – 1) By Product: Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers 2) By Technology: HEPA Filter, Electrostatic Filtration, Microsphere Separation, Hollow Fiber Filtration, Other Technologies 3) By End-User: Homecare settings, Hospitals The respiratory devices and equipment (therapeutic) market size has grown rapidly in recent years. It will grow from $19.9 billion in 2023 to $22.01 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to respiratory conditions prevalence, aging population, technological advancements, respiratory disease management. The respiratory devices and equipment (therapeutic) market size is expected to see rapid growth in the next few years. It will grow to $32.61 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to chronic diseases and lifestyle factors, telehealth expansion, technological innovations, copd management. Major trends in the forecast period include digital health and remote monitoring, ventilators and life support systems, respiratory rehabilitation, telehealth integration.

Rising Respiratory Disease Prevalence Drives Respiratory Devices And Equipment (Therapeutic) Market

The rising prevalence of respiratory diseases such as chronic obstructive pulmonary disorder (COPD) and sleep apnea contributed to the growth of the therapeutic respiratory devices and equipment market. According to World Health Organization, one million people die due to chronic obstructive pulmonary diseases caused by smoking among the 4.9 million people who die due to tobacco consumption and 65 million people suffer from moderate to severe COPD. As per its estimates, COPD is predicted to be the third leading cause of death worldwide and potentially fatal respiratory diseases. Tuberculosis, COPD, and lung cancer will account for about one in five deaths worldwide by 2030. According to National Health Interview Survey by the Centers for Disease Control and Prevention (CDC), the number of adults with diagnosed chronic bronchitis in the USA was 9.0 million. In the USA, it is estimated that 22 million Americans suffer from sleep apnea, with 80% of the cases of moderate and severe obstructive sleep apnea undiagnosed. According to a research study published on American Journal of Respiratory and Critical Care Medicine, in 2021, global prevalence of obstructive sleep apnea was found to be around 20% globally. The increased prevalence of COPD and sleep apnea in the geriatric population is driving the growth of the respiratory devices and equipment (therapeutic) market.

Growing Smoker Population Fuels Demand For Therapeutic Respiratory Devices And Equipment

The increasing number of smokers is expected to propel the growth of the respiratory devices and equipment (therapeutic) market going forward. Smokers refers to individuals who engage in the act of smoking tobacco products, such as cigarettes, cigars, or pipes. Respiratory devices and equipment (therapeutic) such as inhalers and nebulizers are used by smokers to help manage respiratory diseases such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, and lung cancer. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Also, the total number of cigarettes sold rose by 1.3% from May 2022, reaching 1.4 billion in June 2022. Therefore, the increasing number of smokers drives the growth of the respiratory devices and equipment (therapeutic) market. Major companies operating in the respiratory devices and equipment (therapeutic) market include Hamilton Medical AG, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Philips Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Drägerwerk AG & Co. KGaA, Medtronic PLC, Masimo Corporation, CareFusion Corporation, Getinge AB, Hill-Rom Holdings Inc., Becton, Dickinson and Company, Air Liquide S.A., Vyaire Medical Inc., Compumedics Limited, Covidien PLC, Mindray Medical International Limited, Inogen Inc., Nihon Kohden Corporation, Siemens Healthcare GmbH, Teleflex Incorporated, Breas Medical AB, AirSep Corporation, Rotech Healthcare Inc., 3B Medical Inc.

Awareness And Training Challenges In The Respiratory Devices And Equipment (Therapeutic) Market

Lack of awareness regarding the usage of respiratory devices has always been a major challenge in the therapeutic respiratory device market. Outcomes for patients with chronic respiratory diseases remain poor despite the development of novel therapies. An International Survey conducted on Noninvasive Ventilation Use for Acute Respiratory Failure in General Non-Monitored Wards in 51 countries from 5 continents revealed that 44% of the GPs and physicians reported that they had never performed spirometry to make a diagnosis of COPD and the NIV application in general wards was reported by only 66% of respondents. Limited training and human resources were the most common reasons for not using NIV in general wards. The lack of awareness on the use of respiration devices is negatively affecting the respiratory devices and equipment (therapeutic) market.

Innovations In Artificial Intelligence (AI)-Enhanced Respiratory Devices And Monitoring

The companies in the respiratory devices and equipment (therapeutic) market are increasingly using AI to develop respiratory devices to treat Asthma and COPD. Artificial intelligence supports the development of innovative sensors-equipped inhalers which help patients to track their dosage intake. These sensors are durable and consume less power and help caution the patients by noting the differences or fluctuations in respiration. These are used for both add-on and embedded inhalers. These inhalers with sensors can track data automatically and can alert both the doctors and patients about the health condition of the patients. Also, the companies in developing devices such as AI aided imaging systems and AI aided platforms that will act as voice biomarkers. For instance, in March 2022, Respira Labs, a US-based respiratory technology company, launched AI-powered wearable lung monitor ‘Sylvee’. The new product uses acoustic resonance to assess the lung function and detect any variations in the lung function.

Advancements In The Respiratory Devices And Equipment

Major companies operating in the respiratory devices and equipment (therapeutic) market are focusing on innovating products, such as the VitaloPFT series, to provide reliable services to customers. The VitaloPFT series is used as respiratory devices and equipment (therapeutic) to diagnose, monitor, and manage patient’s respiratory health in the most efficient and effective way possible. For instance, in March 2023, Vitalograph Ltd., a UK-based manufacturer of respiratory medical devices, launched the VitaloPFT series. The VitaloPFT series is a device designed to deliver advanced respiratory diagnostic solutions to hospitals and other secondary care units that demand complex pulmonary function testing. The VitaloPFT series includes the VitaloROV+, a portable pulmonary function testing (PFT) device that provides accurate point-of-care testing to patients.

Zoll Medical Corporation Acquisition Of Respicardia Inc. Expands Respiratory And Cardiovascular Solutions Portfolio

In April 2021, ZOLL Medical Corporation, a US-based company that develops medical devices and software solutions, acquired Respicardia Inc. for an undisclosed amount. With this acquisition, ZOLL Medical Corporation aims to expand its portfolio by providing treatment for patients with respiratory and cardiovascular diseases. Respicardia Inc. is a US-based company that develops therapies, devices, and equipment for respiratory and cardiovascular diseases. Asia-Pacific was the largest region in the respiratory devices and equipment (therapeutic) market in 2023. Western Europe was the second-largest region in the respiratory devices and equipment (therapeutic) market. The regions covered in the respiratory devices and equipment (therapeutic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the respiratory devices and equipment (therapeutic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada The respiratory devices and equipment (therapeutic) market consist of sales of instruments such as nebulizers, oxygen concentrators, positive airway pressure devices, ventilators, inhalers, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The respiratory devices and equipment (therapeutic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (therapeutic) market statistics, including respiratory devices and equipment (therapeutic) industry global market size, regional shares, competitors with a respiratory devices and equipment (therapeutic) market share, detailed respiratory devices and equipment (therapeutic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (therapeutic) industry. This respiratory devices and equipment (therapeutic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Respiratory Monitoring Devices Market Definition And Segments

Respiratory monitoring devices are used to assess the patient's respiratory organs and include patches that are placed on the body to measure respiration and heart rates. The main types of respiratory monitoring devices are capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and others. Capnographs are monitoring devices that measure the concentration of carbon dioxide in exhaled air and display a numerical readout and waveform tracing. The various applications involved are chronic obstructive pulmonary disease (COPD), infectious diseases, asthma, and others that are used by end-users such as laboratories, hospitals, and home use. The respiratory monitoring devices market covered in this report is segmented – 1) By Type: Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs, Others Types 2) By Application: Chronic Obstructive Pulmonary Disease (COPD), Infectious Diseases, Asthma, Other Applications 3) By End-User: Laboratories, Hospitals, Home Use The respiratory monitoring devices market size has grown rapidly in recent years. It will grow from $1.5 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to respiratory diseases, aging population, technological advancements, hospital and homecare settings. The respiratory monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.39 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to respiratory health awareness, chronic diseases, remote patient monitoring, wearable technology. Major trends in the forecast period include remote monitoring and telehealth, connected devices and iot, data analytics and artificial intelligence, mobile apps and wearable devices.

Rising Incidence Of Chronic Respiratory Diseases Drives The Respiratory Monitoring Devices Market

The rising rate of chronic respiratory diseases is expected to drive the growth of respiratory monitoring devices market in the near future. Chronic respiratory diseases such as asthma, bronchitis, pneumonia, and others resulting from different bacterial and viral infections will boost the demand for respiratory monitoring devices. For example, in June 2023, according to The Centers for Disease Control and Prevention, a US based public health agency, there were 142,342 deaths in 2021 from chronic lower respiratory diseases. Additionally, in June 2023, according to The Australian Institute of Health and Welfare, a Australia-based national agency Nearly one-third (30%) of Australians, or 7.5 million people, have been diagnosed with chronic respiratory diseases. The respiratory monitoring devices such as spirometers and pulse oximeters act as essential devices to monitor vital respiratory parameters.

Growing Prevalence Of Pneumonia

The growing prevalence of pneumonia is expected to propel the growth of the respiratory monitoring devices market going forward. Pneumonia is an infection that affects one or both lungs, causing the lungs' air sacs, or alveoli, to fill up with fluid or pus. Pneumonia causes an inflammatory reaction in the lungs, increasing blood vessel permeability and fluid leakage into the alveoli. Respiratory monitoring devices can help in the early detection and management of pneumonia by providing real-time and continuous monitoring of respiratory rate and other vital signs. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2021, the number of deaths due to pneumonia in the United States was 41,309, with a mortality rate of 12.4 deaths per 100,000 population. Therefore, the growing prevalence of pneumonia drives the growth of the respiratory monitoring devices market. Major companies operating in the respiratory monitoring devices market include Covidien LLC, GE Healthcare Inc., Philips Healthcare, ResMed Corp., Siemens Healthcare GmbH, Merck & Co. Inc., Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Sirnaomics Inc., Traversa Therapeutics Inc., CareFusion Corporation, Smiths Medical ASD Inc., Masimo Corporation, COSMED S.r.l., IITC Life Science Inc., Micro Idea Instruments Co. Ltd., OES Medical Ltd., Pulmonx Corporation, RWD Life Science Co. Ltd., Scientific Respiratory Equipment Inc., AirSep Corporation, Medtronic PLC, Drägerwerk AG & Co. KGaA, Hamilton Medical India Pvt. Ltd., Getinge AB, Respiratory Motion Inc., Genstar Technologies Co. Inc., Avery Biomedical Devices Inc., Dynarex Corporation, Quality Medical Group Ltd.

Impact Of Prolonged Approval Processes On The Respiratory Monitoring Devices Market

The longer duration of time taken in the approval process of respiratory devices is restricting the growth of the respiratory monitoring devices market. Before a new respiratory device is introduced to the market, it takes 7.2 months for the FDA approval process, which adds to the development costs to be borne by device manufacturers, thus acting as a restraint to the market growth. To reduce incidences associated with respiratory devices and ensure that the devices are safe and have the least adverse reactions, regulatory authorities such as the Medicines and Healthcare products Regulatory Agency (MRHA) in the UK regulates and monitors the devices by restricting devices for use and sending field safety notices to correct the devices. These stringent approval processes and regulatory policies may impact the respiratory monitoring devices market.

Smart Respiratory Monitoring Devices Revolutionize Disease Diagnosis And Management

The companies in the market are increasingly launching smart respiratory monitoring devices to diagnose and monitor some respiratory diseases. These smart respiratory monitoring devices are Bluetooth-enabled and can be connected to smartphones to continuously monitor vital respiratory parameters. For instance, in February 2022, Aptar Pharma, a US-based manufacturer of drug delivery systems, launched HeroTracker® Sense. The new offering is a novel digital respiratory health solution that converts a standard meter dose inhaler into a smart connected healthcare device. It is useful for patients to track their MDI usage and help them stick to their prescribed doses.

Innovative Solutions For Improved Respiratory Care

Major companies operating in the respiratory monitoring devices market are focusing on innovating products, such as the HeroTracker Sense, to provide reliable services to customers. HeroTracker Sense is used as a respiratory monitoring device designed to help address patient inhalation techniques and adherence. For instance, in February 2022, AptarGroup, Inc., a US-based provider of innovative drug delivery systems for pharmaceuticals, launched HeroTracker Sense. HeroTracker Sense is a device that transforms a standard metered dose inhaler (pMDI) into a smart, connected healthcare device. HeroTracker Sense helps asthma and chronic obstructive pulmonary disease (COPD) patients take their medications. This device collects healthcare analytics, enabling doctors and healthcare providers to deliver better care.

Senzime Ab Enhances Product Portfolio And Capabilities With Acquisition Of Respiratory Motion

In June 2022, Senzime AB, a US-based manufacturer of patient monitoring systems, acquired Respiratory Motion for an initial cash payment of $19 million. The acquisition will help Senzime to expand its product portfolio in monitoring devices market and extend company’s capabilities. Respiratory motion is a US-based respiratory medical device manufacturer. Asia-Pacific was the largest region in the respiratory monitoring devices market in 2023. North America was the second-largest region in the respiratory monitoring devices market. The regions covered in the respiratory monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the respiratory monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada The respiratory monitoring devices market consists of sales of pulse oximeters, capnography, spirometers, polysomnography (PSG), peak flow meters, gas analyzers, and others that are used to monitor respiration and heart rate. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The respiratory monitoring devices market research report is one of a series of new reports from The Business Research Company that provides respiratory monitoring devices market statistics, including respiratory monitoring devices industry global market size, regional shares, competitors with a respiratory monitoring devices market share, detailed respiratory monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory monitoring devices industry. This respiratory monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Respiratory Devices And Equipment (Diagnostic) Market Definition And Segments

Respiratory devices and equipment (diagnostic) are used in the diagnosis of respiratory disorders such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease. The main products of the respiratory devices and equipment (diagnostic) market are instruments and devices, assays, and reagents. The respiratory instruments and devices are used to diagnose respiratory disorders. The test type included is traditional diagnostic tests, mechanical tests, imaging tests, and molecular diagnostic tests that are used to diagnose chronic obstructive pulmonary disease, lung cancer, asthma, tuberculosis, and other diseases. These are used in hospital/clinical laboratories, physician offices, reference laboratories, and other end users. The respiratory devices and equipment (diagnostic) market covered in this report is segmented – 1) By Product: Instruments And Devices, Assays And Reagents 2) By Test Type: Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests 3) By Disease Type: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Diseases 4) By End User: Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users The respiratory devices and equipment (diagnostic) market size has grown strongly in recent years. It will grow from $7.4 billion in 2023 to $8.02 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to chronic respiratory diseases, aging population, smoking and environmental factors, technological advancements. The respiratory devices and equipment (diagnostic) market size is expected to see strong growth in the next few years. It will grow to $11.31 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to respiratory infections, telemedicine and remote monitoring, personalized medicine, ai and machine learning. Major trends in the forecast period include pulmonary function testing (pft), home respiratory monitoring, telemedicine integration, smoking cessation aids.

Growing Prevalence Of Respiratory Diseases Boosts Demand For Respiratory Devices And Equipment (Diagnostic) Market

The increasing prevalence of various respiratory diseases contributed to the global respiratory devices and equipment market growth by increasing the use of diagnostic devices and equipment for diagnosis and treatment. Diseases such as chronic obstructive pulmonary disease (COPD) are more prevalent in the geriatric population. COPD is a type of obstructive lung disease that results in long-term breathing problems. For instance, in June 2021, according to the world health organization data, chronic obstructive pulmonary disease (COPD) is the third disease on the list of causing death in the world. There are about 3.23 million deaths that are caused by chronic obstructive pulmonary disease (COPD).. Thus, the increased number of such cases has surged the demand for diagnostic devices and equipment, therefore driving the growth of respiratory devices and equipment (diagnostic) market.

Rise In The Aging Population Drives The Growth Of The Respiratory Devices And Equipment (Diagnostic) Market

The rise in the aging population is expected to drive the growth of the respiratory devices and equipment (diagnostic) market. An aging population refers to a demographic phenomenon characterized by an increasing proportion of elderly individuals within a society or population. Respiratory diagnostic devices and equipment play a crucial role in monitoring and managing respiratory health for the aging population, aiding in early detection and intervention for conditions like COPD and sleep apnea. For instance, in July 2022, according to the United Nations Department of Economic and Social Affairs, a US-based agency dedicated to global economic, social, and environmental issues with a focus on sustainable development, the proportion of the world's population aged 65 and older is expected to increase from 10% in 2022 to 16% by 2050. Therefore, the rise in the aging population drives the growth of the respiratory devices and equipment (diagnostic) market. Major companies operating in the respiratory devices and equipment (diagnostic) market include ResMed Inc., Medtronic PLC, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Dräger Medical GmbH, bioMérieux, Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline PLC, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC

Impact Of Stringent Regulatory Practices On The Growth Of Diagnostic Respiratory Devices

Stringent regulatory practices are expected to negatively impact the growth of diagnostic respiratory devices in the forecast period. In the USA, respiratory devices undergo a strict approval process as they come under Class III devices (that pose a significant risk to patients) as per the Food and Drug Administration (FDA) classification of medical devices. These devices require clinical evidence that supports their intended use unlike, Class I and II devices, to receive marketing approval. In countries such as China, the approval process for medical devices, especially for devices used for support or sustenance, is strict and time-consuming. Such a process has slowed the entry of medical devices into the market, thus restraining the growth.

Innovative Technology-Enabled Respiratory Devices For Immediate Diagnosis

Companies in the market are increasingly investing in portable and wireless diagnostic respiratory devices. The trend is being driven by the ease of handling, cost-effectiveness, advanced features of these devices, and their suitability for use at home care organizations. Innovative technology-enabled portable respiratory devices are being launched into the market, which, unlike traditional devices, can be used for immediate diagnosis of vital signs, for example, the patients’ respiratory rate and the pulse rate. For instance, in July 2021, Tidal Medical Technologies received U.S FDA approval for the use of its InSee incentive spirometer accessory for detection of medical condition and symptoms of COVID-19 in hospital settings.

Introducing Simultaneous Monitoring Oximeters To Gain A Competitive Edge

Major companies operating in the respiratory devices and equipment (diagnostic) market are focused on developing simultaneous monitoring oximeters to gain a competitive edge in the market. Simultaneous monitoring oximeters serve as vital diagnostic respiratory equipment, enabling real-time tracking of oxygen levels, a critical measure for assessing respiratory health. For instance, in November 2021, Masimo Corporation, a US-based medical technology company, launched Dual SET Pulse Oximetry for its Roo patient monitoring and connectivity hub. This innovative technology enables healthcare professionals to concurrently monitor various measurements alongside dual oximetry, offering a more comprehensive perspective on a patient's health status. The initial application of Dual SET Pulse Oximetry is in the screening process for critical congenital heart disease (CCHD). This method optimizes the CCHD screening process and enhances clinical workflows, which is advantageous for both patients and healthcare providers.

Icu Medical Inc. Acquired Smiths Medical

In January 2022, ICU Medical Inc., a US-based medical device company, acquired Smiths Medical for $2.35 billion. This acquisition of Smiths Medical's syringe and ambulatory infusion devices, vascular access solutions, and vital care products was anticipated to bolster the growth of ICU Medical's infusion therapy product range and extend its portfolio into emerging clinical care markets. Smith Medical is a US-based firm that develops, manufactures, and sells medical products, including diagnostic respiratory devices and equipment. Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2023. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the respiratory devices and equipment (diagnostic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada The respiratory devices and equipment (diagnostic) market consist of sales of spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers that are used for diagnosis of respiratory diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The respiratory devices and equipment (diagnostic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (diagnostic) market statistics, including respiratory devices and equipment (diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (diagnostic) market share, detailed respiratory devices and equipment (diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (diagnostic) industry. This respiratory devices and equipment (diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Respiratory Disposables Market Definition And Segments

Respiratory disposables are used to interface respiratory devices with patients, such as ventilators, nebulizers, and oxygen therapy devices. The main types of respiratory disposables are masks, tubes, inhalers, and others. A mask is a piece of cloth or other material that is personal protective equipment intended for medical purposes. These are used for disease indications such as asthma, a chronic obstructive pulmonary disorder, tuberculosis, lung cancer, and other chronic respiratory diseases. The applications involved in adult, pediatric, and neonatal. The various end-users are hospitals, clinics, ambulatory care centres, and others. The respiratory disposables market covered in this report is segmented – 1) By Type: Masks, Tubes, Inhalers, Other Types 2) By Disease Indications: Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respiratory Diseases 3) By Application: Adult, Pediatric & Neonatal 4) By End User: Hospitals, Clinics, Ambulatory Care Centers, Other End Users The respiratory disposables market size has grown rapidly in recent years. It will grow from $3.08 billion in 2023 to $3.42 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to respiratory conditions prevalence, infection control, aging population, respiratory therapies. The respiratory disposables market size is expected to see rapid growth in the next few years. It will grow to $5.04 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to minimally invasive respiratory procedures, emerging markets growth, telehealth and remote monitoring, value-based healthcare. Major trends in the forecast period include eco-friendly disposables, customized solutions, remote monitoring and data integration, advanced filter technology.

Prevalence Of Respiratory Diseases Fuels Demand For Respiratory Disposables

The high prevalence rate of respiratory diseases globally is driving the respiratory disposables market. Excessive smoking, exposure to toxic materials, adverse climate conditions, and air pollution are some of the main causes that are leading to a rise in respiratory diseases such as asthma, lung cancer, Chronic Obstructive Pulmonary Disease (COPD), and obstructive sleep apnea (OSA). According to a study, around 65 million people suffer from chronic obstructive pulmonary disease (COPD) and around 3 million people die every year because of this disease. It was also reported that around 334 million people suffer from asthma diseases caused by air pollution as well as tobacco smoke, toxic disposable devices. These factors are increasing the demand for the treatment of respiratory ailments, thus driving the respiratory diseases market.

Surging Demand For Telehealth Accelerates Growth Of The Respiratory Disposables Market

The increasing demand for telehealth is expected to propel the growth of the respiratory disposables market going forward. Telehealth refers to the use of telecommunications technology, such as videoconferencing, phone calls, and secure messaging, to provide healthcare services remotely. Telehealth allows patients to have remote consultations with healthcare providers for respiratory conditions. During these virtual visits, healthcare professionals can assess patients' symptoms and recommend appropriate treatment, including the use of respiratory disposables such as masks, nebulizers, or inhalers. For instance, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023, there was a 7.3% national rise in telehealth use. Therefore, the increasing demand for telehealth is driving the growth of the respiratory disposables market. Major companies operating in the respiratory disposables market include Fisher & Paykel Appliances Holdings Ltd., Becton Dickinson Company, Ambu A/S, Smiths Medical Inc., Armstrong Medical, Teleflex Incorporated, Philips Respironics, Besmed, ResMed, Dynarex Corporation, Drive Medical, Cardinal Health Inc., Drger Medical, Hamilton Medical, Mercury Medical, SunMed LLC, Ningbo Greetmed Medical Instruments Co.Ltd., Hangzhou Jinlin Medical Appliances Co. Ltd., Hangzhou Tappa Medical Technology Co. Ltd., Weihai Strong Medical Sci-Tech Co.Ltd., Vyaire MedicalInc., Viomedex Ltd., Flexicare Medical Ltd., ICU Medical Inc., GF Health Products Inc., Medline Industries Inc., Westmed Inc., Intersurgical Ltd., Salter Labs Inc., AirLife, Medtronic PLC, McKesson Corporation, Owens & Minor Inc., Henry Schein Inc., 3M Company, Johnson & Johnson, Baxter International Inc.

Stringent Regulatory Policies Impede Growth Of The Respiratory Disposables Market

The respiratory disposables market is being restrained due to stringent regulatory policies. Regulatory agencies and governments across various countries are imposing stringent restrictions on product approval and launch, this is limiting the market growth. For instance, the FDA banned Amphastar Pharmaceutical’s Primatene product, an albuterol CFC inhaler for asthma because ozone-depleting chlorofluorocarbon (CFC) propellants have depleted the ozone layer. The FDA rejected Amphastar’s first attempt to bring a reformulated version of Primatene mist to market. The FDA rejected another application for Primatene Mist. This resulted in a rise in development costs and potential sales loss due to delays in product launch, thus restraining the Respiratory disposables market.

Innovative Technologies Transforming Respiratory Disposable Manufacturing

Rapid advances in technology are driving innovation in respiratory disposable manufacturing. Areas of particular development are likely to be AIR gel technology, wearable technologies, and 3D printing technology. These technologies are being used in the manufacturing of respiratory disposables, resulting in higher productivity, lower costs, and higher margins. Companies in this market are increasingly focusing on AIR gel technology, in which gel is incorporated into the bag on the edges of the mask which helps to the protection of the skin and creates a bridge to minimize the irritation of the skin and for effective sealing. For example, Vyair medical prepared Veraseal 2 disposable mask, used for acute care with AIR gel technology and the advantage of vented and non-vented versions. Similarly, Sleepnet prepared Mojo ventilation masks with Airgel technology.

Leading Companies Introduce Innovative Products Like The Dc365 Small Surgical N95 Respirator To Enhance Respiratory Disposables Market

Major companies operating in the respiratory disposables market are innovating new products such as small surgical N95 respirator to increase their profitability in the market. The small surgical N95 Respirator is a product made to safeguard the respiratory system of medical workers. For instance, in May 2022, Honeywell International, Inc., a US-based Multinational conglomerate corporation launched DC365 Small Surgical N95 Respirator. The respirator is flexible and lightweight, dye-free, non-sensitizing, and conforms nicely to the face while reducing pressure points. The materials used in the DC365 Small Surgical N95 Respirator are supple and comfortable close to the skin since they were created with comfort in mind.

Medline Expands Respiratory Product Portfolio With Hudson Rci Acquisition

In 2021, Medline a Netherland-based medical device company acquired the Hudson RCI brand of respiratory consumables from Teleflex. The acquisition helps Medline's offerings, enlarging the respiratory environment with the highly regarded Hudson RCI products and opening extra opportunities for development and help to customers. Teleflex is a US-based company global provider of medical technologies designed to develop the health and quality of people's lives. Asia-Pacific was the largest region in the global respiratory disposables and equipment market in 2023. Western Europe was the second-largest region in the respiratory disposables market. The regions covered in the respiratory disposables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the respiratory disposables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada. The respiratory disposables market consists of sales of instruments such as disposable resuscitators, disposable masks, nasal cannulas, tracheostomy tubes, and other consumables and accessories. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The respiratory disposables market research report is one of a series of new reports from The Business Research Company that provides respiratory disposables market statistics, including respiratory disposables industry global market size, regional shares, competitors with a respiratory disposables market share, detailed respiratory disposables market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disposables industry. This respiratory disposable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anesthesia And Respiratory Devices Market Definition And Segments

Anesthesia and respiratory devices are used in the diagnosis and treatment of respiratory diseases. This market includes respiratory devices that are used to provide medication for medical conditions such as asthma, cystic fibrosis, acute respiratory distress syndrome, and others. The main types of anesthesia and respiratory devices are respiratory devices and equipment (therapeutic and diagnostic), anesthesia machines, anesthesia disposables, and respiratory disposables. The respiratory disposables are designed to be discarded after excessive breathing resistance, sorbent exhaustion, physical damage, or end-of-service life renders them unsuitable for use. The type of expenditure is public and private and the products used are instruments/equipment and disposables by various genders such as male and female and used in multiple end-users including hospitals and clinics, diagnostic laboratories, and others. The anesthesia and respiratory devices market covered in this report is segmented – 1) By Type: Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables 3) By Type of Expenditure: Public, Private 4) By Product: Instruments or Equipment, Disposables 5) By Gender: Male, Female 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users The anesthesia and respiratory devices market size has grown rapidly in recent years. It will grow from $57.98 billion in 2023 to $64.96 billion in 2024 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to the increased prevalence of respiratory diseases, the COVID-19 pandemic, increased number of surgical procedures, strong economic growth in emerging markets, increased healthcare expenditure, and a growing aging population. The anesthesia and respiratory devices market size is expected to see rapid growth in the next few years. It will grow to $99.53 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to the increasing prevalence of obstructive sleep apnea, technological advances, increasing use of tobacco smoking, rise in healthcare expenditure, and increasing geriatric population. Major trends in the forecast period include producing smart inhalers, investing in the research and development of wearable respiratory devices, launching new innovative products, producing portable respiratory devices, and others. player-adopted strategies in the anesthetics and respiratory devices market include investing in expanding operations through innovative product launches, and in acquisitions and mergers to strengthen their service offerings.

Rising Respiratory Diseases Rates Fuel Surge In Demand For Anesthesia And Respiratory Devices

The increased prevalence of respiratory diseases is expected to drive the growth of the anesthesia and respiratory devices market. Respiratory disease refers to medical conditions that interfere with breathing and gas exchange by affecting the organs and tissues of the lungs and airway systems. Anesthesia and respiratory equipment are integral to the treatment of respiratory diseases such as tuberculosis by facilitating necessary medical procedures, ensuring patient comfort and safety, and aiding in the monitoring and management of the disease. For instance, in October 2022, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based global health agency, the global incidence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 population in 2021, an increase of 4.5% from 10.1 million in 2020. The majority of TB cases were reported in the Southeast Asia region, accounting for 45% of the total, followed by Africa with 23% of the cases in 2021. Therefore, the increased prevalence of respiratory diseases will propel the growth of the anesthesia and respiratory devices market going forward.

Rising Healthcare Expenditures Expected To Propel Anesthesia And Respiratory Devices Market Growth

Increasing healthcare expenditures are anticipated to propel the growth of the anesthesia and respiratory devices market. Healthcare expenditures refer to the total amount spent on healthcare-related services, products, and activities within a specified period, typically on an individual, community, national, or global level. With the escalation of healthcare expenditures, there is typically a heightened emphasis on delivering superior healthcare services, encompassing surgical and respiratory care, thus generating a demand for cutting-edge devices that have the potential to enhance patient outcomes. For instance, in May 2023, according to the Office for National Statistics, a UK-based statistics authority, it is estimated that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. UK total healthcare expenditure in 2021 was $367.25 billion (£280.7 billion), and pharmaceutical expenditure was $51.84 billion (£39.6 billion) in 2021. Furthermore, spending on preventive care was $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Therefore, increasing healthcare expenditure will drive the growth of the anesthesia and respiratory devices market going forward. Major companies operating in the anesthesia and respiratory devices market report are ResMed Inc., Koninklijke Philips N.V., General Electric Company, Cardinal Health, Inc., Medtronic PLC, Fisher & Paykel Healthcare Corporation Limited, Draegerwerk AG, Teleflex Inc., Vyaire Medical, Inc., Smith Group Plc., GE Healthcare, Covidien Healthcare, Metran Co., Ltd., Siemens Healthcare, Opto Circuits, Roche, AstraZeneca, B. Braun, Melsungen, Masimo Corporation, Dixion, SunMed, Getinge Group, CapeRay, Centre for Rapid Prototyping and Manufacturing (CRPM), DISA Vascular, Sinapi biomedical, Ti-TaMED.

Innovative Products Like Lifebox-Smile Train Pulse Oximeter Drives Profitability

Major companies operating in the anesthesia and respiratory devices market are innovating new products, such as the Lifebox-Smile Train pulse oximeter, to increase their profitability in the market. The Lifebox-Smile Train pulse oximeter is a low-cost device that can monitor the oxygen saturation of patients during surgery, making anesthesia safer. For instance, in July 2022, Smile Train Inc., a US-based nonprofit organization and charity providing corrective surgery for children with cleft lips and palates, launched the Lifebox-Smile Train pulse oximeter. The Lifebox-Smile Train pulse oximeter is a low-cost device that can monitor the oxygen saturation of patients during surgery, making anesthesia safer.

The Surge In Wearable Respiratory Devices Enhancing Patient Monitoring And Healthcare Efficiency

The preference for wearable and portable medical devices is increasing and companies in the anesthesia and respiratory devices market are developing wearable respiratory devices to improve patient monitoring. Wearable respiratory devices are mainly worn on the torso and are used to calculate the patient’s breathing rate by measuring the movements of the chest wall. They are available in various forms such as small dimensional sensors, belts, and band-aid-like devices. These devices are usually connected to specialty smartphone apps that capture and interpret data and store the data in cloud data repositories focusing on main areas of respiratory healthcare including pulse oximetry, pulmonary ventilation, air quality assessment, and activity tracking. Wearable respiratory devices reduce the workload of healthcare providers, improve the efficiencies of diagnostics, reduce costs incurred by patients in regular checkups, and improve patients’ comfort. For instance, researchers at the University of California and Khine Labs are investing in major research projects to develop comfortable wearables for patients suffering from respiratory diseases. Asia-Pacific was the largest region in the global anesthesia and respiratory devices market in 2023. North America was the second largest region in the global anesthesia and respiratory devices market. Eastern Europe was the smallest region in the global anesthesia and respiratory devices market. The regions covered in the anesthesia and respiratory devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the anesthesia and respiratory devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa The anesthesia and respiratory devices market consists of sales of instruments such as resuscitators, laryngoscopes, flexible intubation scopes, supraglottic airways, ventilator circuits, HME, and other anesthesia and respiratory instruments that are used for the diagnosis and treatment of respiratory diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The anesthesia and respiratory devices market research report is one of a series of new reports from The Business Research Company that provides anesthesia and respiratory devices market statistics, including anesthesia and respiratory devices industry global market size, regional shares, competitors with anesthesia and respiratory devices market share, detailed anesthesia and respiratory devices market segments, market trends and opportunities, and any further data you may need to thrive in the anesthesia and respiratory devices industry. This anesthesia and respiratory devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Masks (N95 Respirators And Other Surgical Masks) Market Definition And Segments

The N95 respirators and other surgical masks are used as personal protective equipment to protect the wearer from airborne particles and liquid contaminating the face. The N95 respirators and other surgical masks are available in a variety of thicknesses and liquid contact protection levels. These characteristics may also have an impact on how readily people can breathe through the surgical mask and how well it protects people. The main types of N95 respirators and other surgical masks are N95 respirators, common grade surgical masks, and others (comfort masks/dust masks). N95 respirators are particulate-filtering respirators that are utilized to save the wearer from particles or liquid contaminating the face. These are either reusable or disposable that are used in hospitals and clinics, individuals, industrial, and others. The masks (N95 respirators and other surgical masks) market covered in this report is segmented – 1) By Type: N95 Respirator, Common Grade Surgical Masks, Others (Comfort Masks/Dust Masks) 2) By End User: Hospitals and Clinics, Individual, Other End Users 3) By Nature: Reusable, Disposable The masks (N95 respirators and other surgical masks) market size has grown strongly in recent years. It will grow from $14.49 billion in 2023 to $15.6 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to impact of COVID-19 pandemic, rising air pollution levels, escalating number of smokers, increased number of surgical procedures, a rise in healthcare expenditure, and increased geriatric population. The masks (N95 respirators and other surgical masks) market size is expected to see strong growth in the next few years. It will grow to $21.22 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to new COVID-19 strains, a rise in airborne diseases, government initiatives, and a rise in online pharmacies. Major trends in the forecast period include development of n95 masks with added bluetooth technology, integration new technologies to enhance customer satisfaction, technological advancements, increasing mergers and acquisition activity, investing in biodegradable and reusable materials, nanotechnology, manufacturing of personalized or customized masks, and development of reusable silicon masks.

Exponential Growth In The N95 Respirators And Surgical Masks Market Amidst The COVID-19 Pandemic

The N95 respirators and other surgical masks market is experiencing exponential growth due to the COVID-19 pandemic. This is because the COVID-19 is a severe acute respiratory syndrome, which can be transmitted through airborne droplets, which masks can potentially block. Masks are therefore essential equipment for staff dealing with infectious patients. In addition, many other workers and individuals are using face masks as a precautionary measure.

Surge In Airborne Disease Outbreaks Fuels Growth In The Masks Market

The rise in the outbreak of airborne diseases contributed to the growth of the masks market. Airborne transmission of infectious agents refers to the transmission of disease caused by the dissemination of droplet nuclei that remain infectious when suspended in air over long distances and time. Precautions that create a barrier and procedures that decrease or eliminate the microbe in the environment or on personal belongings, form the basis of interrupting transmission of direct contact diseases. The spread of airborne diseases like seasonal influenza kills 200–500 thousand people annually, influenza A (H1N1) caused about 700 deaths in 2020-2021 season in the US, many of whom were healthy adults. These recent outbreaks remind us of the potential for a pandemic such as the Spanish flu of 1918–1920 which killed 50–100 million people and now it is the recent outbreak of COVID-19. This is expected to drive the growth of the N95 respirators and other surgical masks market by several folds in the short term.

Surge in Construction Activities Boosts Growth of Masks Market

The increasing construction activities are expected to propel the growth of the masks (N95 respirators and other surgical masks) market going forward. The construction sector refers to the business of manufacturing and commerce concerned with constructing, upholding, and fixing structures. N95 masks are also used in the construction industry to protect workers from other airborne hazards such as welding fumes, mold, and asbestos. For instance, in September 2021, according to a report published by Oxford Economics, a UK-based economic information services company, the global construction output was $10.7 trillion in 2020, and between 2020 and 2030, it is anticipated to increase by 42%, or $4.5 trillion, to reach $15.2 trillion. Therefore, the increasing construction activities are driving the growth of the masks (N95 respirators and other surgical masks) market. Major companies operating in the masks (n95 respirators and other surgical masks) market report are Honeywell International Inc., BYD Co.Ltd., The 3M Company, Intco Medical Technology Co. Ltd., Unicharm Corporation, Moldex-Metric, Kimberly-Clark Corporation, Alpha Pro-Tech, Prestige Ameritech, Ltd., The Gerson Company, Halyard Health, Salus Products, Louis M. Gerson Company, Inc., Shanghai Dasheng Health Products Manufacture Company, Ltd., DuPont, Toray Industries, Koken, Yamamoto Kogaku, Protect U, GE Healthcare, MSA Safety, Ambu, Teleflex, Irema, Kolmi-Hopen, Segetex-EIF, Macopharma, Paul Boyé Technologies, Cambridge Mask Co, Vostok Service, Technoavia, TD Trakt, Zelinsky Group Ltd., Respiratorniy Kompleks, Alvateks, CERVA GROUP a.s, Medline Industries, Johnson and Johnson, Dukal Corporation, Key Surgical, Dynarex Corporation, BD, Canada Medical Ltd., Medicom, CPMC, Fine Hygienic Holding, FLOWTRONIX, GreenLine, U-Mask

Environmental Concerns Surrounding Non-Woven Disposable Masks

Concerns regarding the disposal of non-woven disposables have always been a major challenge. Non-woven disposable surgical masks are made up of polypropylene which is a non-biodegradable material that cannot be decomposed by natural means. According to World Bank research, nearly 1.3 billion tons of municipal solid waste are produced worldwide each year. It is estimated that about 19 billion tons of solid waste will be produced annually by 2025 worldwide. These factors are expected to have a negative impact on the disposable surgical mask market as regulatory agencies will take stringent actions regarding the disposal of these non-biodegradable masks. This may have a negative impact on the market.

Shift Towards Disposable Devices In Developed Countries

The shift towards disposable devices in developed countries is one of the major trends in the N95 respirators and other surgical masks market. Disposable masks eliminate the need for product sterilization and reduce cross-contamination with other reusable products. They are also cost-effective, prevent contamination, and reduce hospital stay, whereas reusable non-woven, masks need to be decontaminated, washed, sterilized for every reuse. Although, reusable surgical face masks can be sterilized and laundered for reuse but are less protective and more time-consuming for production as well as washing and sterilization for reuse. According to the FDA, surgical masks are not intended to be used more than once. This can rise the adoption of disposable respiratory masks. Disposable surgical face masks are often perceived to have protective advantages over reusable surgical face masks as they must be immediately discarded as bio-hazardous materials.

Incorporation Of Authentication And Traceability Technology

Major companies operating in the masks (N95 respirators and other surgical masks) market are focused on incorporating new technologies, such as authentication and traceability technology, into their products to gain a competitive edge in the market. Authentication and traceability technology in masks refers to the use of technology to prevent the use of counterfeit masks, which can be ineffective and pose a risk to the user. For instance, in October 2021, Aegle, a US-based health-tech company, launched the first N95 and NIOSH (National Institute for Occupational Safety and Health)-certified mask that uses authentication and traceability technology. The N95 mask has been carefully designed with safety, comfort, and physical improvements in mind. The masks' outstanding fit and breathability are made possible by their ultra-lightweight construction. Each Aegle N95 mask is built to efficiently secure mask insertion, restrict mask movement, and provide the highest level of visibility, reducing inhalation exposure to airborne biological particles including COVID-19, Bacillus anthracis, and Mycobacterium tuberculosis. North America was the largest region in the N95 respirators and other surgical masks market in 2023. Asia-Pacific was the second largest region in the N95 respirators and other surgical masks market share. The regions covered in the masks (N95 respirators and other surgical masks) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the masks (N95 respirators and other surgical masks) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain The N95 respirators and other surgical masks market consists of sales of masks and respirators. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The N95 respirators and other surgical masks (face masks) market research report is one of a series of new reports from The Business Research Company that provides N95 respirators and other surgical masks (face masks) market statistics, including N95 respirators and other surgical masks (face masks) industry, global masks (N95 respirators and other surgical masks) market, regional shares, competitors with a N95 respirators and other surgical masks (face masks) market share, detailed N95 respirators and other surgical masks (face masks) market segments, masks (N95 respirators and other surgical masks) market trends and opportunities, and any further data you may need to thrive in the N95 respirators and other surgical masks (face masks) industry. This N95 respirator and other surgical masks (face masks) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical Equipment Market Definition And Segments

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various products are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centers, and others. The medical equipment market covered in this report is segmented – 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices. 2) By Type Of Expenditure: Public, Private 3) By Product: Instruments And Equipment, Disposables And Consumables 4) By End User: Hospitals And Clinics, Homecare And Diagnostic Centers, Other End Users Sub segments: Point-Of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment., Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment., Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, And Operating Room Equipment., Surgical Sutures And Staples, Handheld Surgical Devices And Equipment And Electrosurgical Devices And Equipment., Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, And Craniomaxillofacial (CMF) Devices And Equipment., Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, And Remote Patient Monitoring Devices And Equipment., Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment And Blood Glucose Meters., Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment And Endoscopy Devices And Equipment., Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints., Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables., Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, And Neurostimulation Devices., Traditional Adhesive Dressings, Negative-Pressure Wound Therapy (NPWT), Traditional Gauze Dressings, And Advanced Wound Care Devices. The medical equipment market size has grown strongly in recent years. It will grow from $709.55 billion in 2023 to $775.42 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increased healthcare expenditure, strong economic growth in emerging markets, growth in the number of healthcare facilities and an increased number of surgical procedures. The medical equipment market size is expected to see strong growth in the next few years. It will grow to $1,077.6 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rapid growth in the elderly population, an increasing prevalence of chronic diseases and government support. Major trends in the forecast period include developing new technological solutions, focusing on expansion of medical equipment manufacturing facilities, focusing on expansion of medical equipment manufacturing facilities, focusing on partnerships and collaborations, focusing on cardiovascular devices manufacturing and focusing on hybrid imaging technologies.

Surge In Cardiovascular Disease Prevalence Drives Growth In The Medical Equipment Market

The rising prevalence of cardiovascular diseases is expected to drive medical equipment market growth. Cardiovascular disease (CVD) is a broad term that refers to a condition that affects the heart or blood vessels. It is often linked with the accumulation of fatty substances within the arteries (atherosclerosis) and an elevated risk of blood clots. Cardiovascular diseases require the use of various medical equipment for their prevention, diagnosis, and treatment. For instance, according to the Centers for Disease Control and Prevention, a US-based national public health agency, heart disease was responsible for the deaths of about 695,000 people in the United States in 2021, which is equivalent to 1 in every 5 deaths. Therefore, the rising prevalence of cardiovascular diseases will fuel the growth of the medical equipment market going forward.

Changing Disease Landscape And Its Impact On Medical Equipment Demand

The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. For instance, in January 2023, according to a report published by the National Library of Medicine, a US-based agency, the number of individuals aged 50 years and older with one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Major companies operating in the medical equipment market report are Medtronic Inc, Abbott Laboratories, Johnson & Johnson, Siemens AG, Becton Dickinson and Company(BD), STRYKER CORPORATION, Cardinal Health, Danaher Corporation, Boston Scientific Corporation, Koninklijke Philips N.V., SCHILLER Healthcare India Pvt. Ltd, GE Healthcare, Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smiths Medical India Pvt Ltd, Agappe Diagnostics Ltd, ARKRAY Healthcare Pvt. Ltd, Accord Medical Products Private Limited, Shinva Medical Instrument Company Limited, Shandong WeiGao Group Medical Polymer Company Limited, Lepu Medical Technology Company (Beijing) Co., Ltd, Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, Terumo Corporation, Olympus Medical Systems Corporation, Canon Medical Systems Corporation, Hitachi Group, Nihon Koden Corporation, Sanko Manufacturing Co.,Ltd, Fukuda Denshi, Metran Co. Ltd, Clarity Medical, Welcare Industries S.P.A, F.L. Medical S.r.l, Empire MEDICAL UK LTD, Europlaz Technologies Ltd, Alfa-Med LLC, Medplant LLC, Medical-Lomza Sp. z o.o., P.H.U. Medical, ProVeterináre, Panop CZ, Baxter, SunMed, Beckman Coulter, Draegerwerk AG, Getinge Group, Masimo, Teleflex Inc, Nipro Medical Ltda, LINET Brazil, Fotoptica Ltda, Leistung Engineering Pvt. Ltd, Saudi Mais Co. for Medical Products (SMMP), Life Pulse Medical Co, Watan, AlKawashef, 3BY Ltd, Qatari German Medical Devices Co, Israeli Hospitals Ltd, CAPS Medical, Amana Healthcare (Pty) Ltd, CapeRay, TiTaMED (Pty) Ltd, Sinapi Biomedical, Egyptian Medical And Environment Group, ResMed Inc

Impact Of Regulatory Changes On The Medical Equipment Market: Increased Costs And Delays In New Product Development

Regulatory changes are expected to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection, such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookie data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy for individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market.

Innovative Easyfuse Dynamic Compression System For Enhanced Foot And Ankle Surgical Applications

Major companies operating in the medical equipment market are innovating new products, such as the EasyFuse Dynamic Compression System, to increase their profitability in the market. EasyFuse Dynamic Compression System is a comprehensive super-elastic nitinol staple system designed to provide fast and easy fixation in high-demand applications of the foot and ankle. For instance, in May 2022, Stryker Corporation, a US-based medical technology company, launched the EasyFuse Dynamic Compression System. The system is engineered to simplify surgical procedures, offer robust dynamic-compression implants, and minimize surgical waste. The EasyFuse system incorporates an exceptionally broad staple bridge intended to evenly distribute forces and ensure consistent implant strength.

Enhancing Patient Care Through Integration Of Medical Device Data With EMR And Wearable Technologies

Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing, and companies are investing in deploying data management, warehousing, and security technologies. For instance, Medtronic Plc, a US-based medical device company, launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. North America was the largest region in the global medical equipment market in 2023. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the medical equipment market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory diseases drugs market consists of sales of respiratory diseases drugs and related services by entities (organizations, sole traders and partnerships) that produce drugs to treat respiratory diseases such as asthma, acute bronchitis, emphysema, cystic fibrosis and other diseases. This industry includes establishments that produce anti-asthmatics and COPD drugs to prevent acute attacks caused by respiratory diseases and cough and cold preparations to treat cough and cold. Some of the major drugs in the market include antimuscarinics, corticosteroids, Codral®, Coldrex® and Lemsip®. The main types of respiratory diseases drugs are anti-asthmatics and copd drugs, cough and cold preparations. Any medication that relieves the symptoms of asthma is considered an anti-asthmatic drugs. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others. The global respiratory diseases drugs market size is expected to decline from $142.57 billion in 2021 to $154.79 billion in 2022 at a compound annual growth rate (CAGR) of 8.6%. The change in the respiratory diseases drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The respiratory diseases drugs market is expected to reach $292.01 billion in 2026 at a CAGR of 17.2%. During the forecast period, the growth of the respiratory diseases drugs market will be restrained by patent expiration of branded respiratory diseases drugs. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patency period, the company holding the patent holds exclusivity for the manufacturing and distribution of drugs. Post expiration of patency, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. Overall, this will negatively impact the growth of the market in terms of value. Companies in the respiratory drugs market are offering drugs for customized individual treatment for better treatment against respiratory diseases. Personalized medicine, also referred to as precision medicine, aims to provide medical care according to the patient’s individual characteristics and genetic makeup. Precision therapies are increasingly being adopted in the respiratory drugs market as firms increasingly let go of the one-size-fits-all model for common respiratory conditions. Companies such as GSK, Teva Pharmaceuticals and AstraZeneca have already invested in personalized medicine for respiratory issues such as asthma. For example, PTC Therapeutics, is developing a drug, which aims to cater to a respiratory mutation which affects about 10% of the population. Companies manufacturing respiratory drugs are increasingly using biomarkers in the drug development process to reduce the time taken to bring the product into the market. Biomarkers are biological indicators which are objectively measured and evaluated for biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention. It can also help predict the drug efficacy faster than conventional clinical endpoints, the point at which an undesired or abnormal effect of the drug is observed indicating withdrawal from therapy. Companies in this market are investing in the development of biomarkers for use in various activities such as tracking drug activity, the pharmacodynamics (relationship between the drug concentration at the site of action and the biochemical and physiological effect) of drugs and to study diseases and treatment pathways. Companies such as Genentech and Janssen are increasingly investing in the use of biomarkers for understanding the efficacy of a potential respiratory drug. For example, Janssen has partnership with U-BIOPRED (unbiased biomarkers in prediction of respiratory disease outcomes), a group in Europe that aims to understand more about severe asthma. Major companies in the respiratory diseases drugs market include Boehringer Ingelheim GmbH, Vertex Pharmaceuticals, AstraZeneca, Pfizer Inc., GlaxosmithKline, Novartis AG, Johnson & Johnson, Reckitt Benckiser Group plc, Mylan N.V., and Sanofi S.A. North America was the largest region in the respiratory diseases drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the respiratory diseases drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the respiratory diseases drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The global respiratory diseases drugs market is segmented - 1) By Type: Anti-Asthmatics and COPD Drugs, Cough and Cold Preparations 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others 3) By Route of Administration: Oral, Parenteral, Others 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs